ACTOS MDL Established

On December 29, 2011 the Judicial Panel on Multidistrict Litigation (JPML) established MDL No. 2299 for all federal claims alleging injury caused by the diabetes drug Actos.  Actos, manufactured by Takeda Pharmaceuticals America Inc., is the tenth best-selling medication in the U.S. and has been found to increase the risk of developing bladder cancer in…

Details

Warning renewed for Baby Acetaminophen

The FDA has renewed a warning about the potential for dosing errors with liquid acetaminophen products for infants. FDA advisory committees made recommendations in 2009 that all liquid acetaminophen be produced in a single concentration: 160mg/5mL. The recommendation was voluntary and not all manufacturers have followed it so there are still products with strengths of…

Details